Novartis5d
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Basel, March 20, 2025 – Novartis today announced that oral Fabhalta ® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G) ...
Novartis2d
Novartis Indonesia
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
Novartis2d
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis2d
Buscar vagas
(高级）医药代表 /（资深）产品专员 Regulär (Außendienst), Full time Innovative Medicines China Kunming (Yunnan Province) março 11, 2025 (高级 ...
Novartis3d
Caută un job
Explorați mai jos oportunitățile de carieră la Novartis.
Novartis3d
Carrières zoeken
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search. Medical Science Liaison Manager, RLT ...
Novartis3d
Procurar vagas
Marketing Director Regular, Full time Innovative Medicines China Shanghai (Shanghai) Março 13, 2025 ...
Novartis3d
Nové pracovní příležitosti
Prozkoumejte pracovní příležitosti ve společnosti Novartis v seznamu níže. Pro další pozice ve společnosti Novartis Gene Therapies (dříve AveXis) navštivte GTx Hledání práce. Medical Science Liaison ...